XML 58 R83.htm IDEA: XBRL DOCUMENT v2.4.0.8
Share-Based Compensation (Details) (USD $)
12 Months Ended 1 Months Ended 12 Months Ended 12 Months Ended 0 Months Ended 0 Months Ended
Feb. 01, 2014
plan
Feb. 02, 2013
Jan. 28, 2012
Jan. 31, 2014
Maurice Marciano
Jan. 28, 2012
Maurice Marciano
Jan. 28, 2012
Maurice Marciano
Feb. 01, 2014
Equity Incentive Plan 2004
Feb. 02, 2013
Equity Incentive Plan 2004
Feb. 01, 2014
2006 Non-Employee Directors Stock Grant and Stock Option Plan
Feb. 02, 2013
2006 Non-Employee Directors Stock Grant and Stock Option Plan
May 09, 2006
2006 Non-Employee Directors Stock Grant and Stock Option Plan
Jul. 30, 1996
2006 Non-Employee Directors Stock Grant and Stock Option Plan
Feb. 01, 2014
Stock option
Feb. 02, 2013
Stock option
Jan. 28, 2012
Stock option
Feb. 01, 2014
Stock option
Selling, general and administrative expenses
Feb. 01, 2014
Stock option
Equity Incentive Plan 2004
Feb. 01, 2014
Nonvested stock awards or units
Feb. 02, 2013
Nonvested stock awards or units
Jan. 28, 2012
Nonvested stock awards or units
Feb. 01, 2014
Nonvested stock awards or units
Selling, general and administrative expenses
Feb. 01, 2014
Nonvested stock awards or units
Equity Incentive Plan 2004
Feb. 01, 2014
Employee Stock Purchase Plan
Feb. 02, 2013
Employee Stock Purchase Plan
Jan. 28, 2012
Employee Stock Purchase Plan
Jan. 23, 2002
Employee Stock Purchase Plan
May 01, 2008
Performance awards/units
Jul. 11, 2013
Performance awards/units
Paul Marciano
Jul. 11, 2013
Target performance awards/units
Paul Marciano
Feb. 01, 2014
Target performance awards/units
Paul Marciano
Oct. 30, 2008
Performance options
Disclosure of share-based compensation information under stock plans                                                              
Number of share-based compensation plans 4                                                            
Authorized number of shares             20,000,000   2,000,000   1,000,000 1,000,000                           4,000,000          
Shares available for grant under the plan             12,151,436 12,835,693 860,432 899,931                                          
Term of award                                 10 years                            
Portion of vested exercisable shares granted on each anniversary from the date of the grant                                 25.00%         25.00%                  
Initial vesting period of the first of three most recent annual grants (in months)                                 9 months                            
Initial vesting period of the second of three most recent annual grants (in months)                                 9 months                            
Initial vesting period of the last of three most recent annual grants (in months)                                 9 months                            
Number of annual vesting periods following the initial vesting period (in years)                                 3 years                            
The purchase price expressed as a percentage of the Company's common stock at the beginning or end of the quarterly stock purchase period                                             85.00%                
Term of consulting agreement         2 years                                                    
Consulting agreement, number of years during the extension period       1 year                                                      
Original grant date fair value of the modified equity awards           $ 4,700,000                                                  
Modified grant date fair value           5,000,000                                                  
Nonvested stock awards or units granted (in shares)                                   819,966                 167,000 100,000 143,700    
Vesting period                                                     5 years 2 years     4 years
Share-based compensation expense 13,949,000 16,285,000 28,100,000     2,500,000             2,490,000 4,633,000 7,123,000 2,490,000   11,225,000 11,337,000 20,584,000 11,225,000   234,000 315,000 393,000            
Number of Shares                                                              
Options outstanding at the beginning of the period (in shares) 1,814,466                                                            
Granted (in shares) 583,500                                                           563,400
Exercised (in shares) (245,350)                                                            
Forfeited (in shares) (370,690)                                                            
Expired (in shares) 0                                                            
Options outstanding at the end of the period (in shares) 1,781,926 1,814,466                                                          
Exercisable at the end of the period (in shares) 1,150,655                                                            
Options exercisable and expected to vest at the end of the period (in shares) 1,718,223                                                            
Weighted Average Exercise Price                                                              
Options outstanding at the beginning of the period (in dollars per share) $ 30.57                                                            
Granted (in dollars per share) $ 26.87                                                            
Exercised (in dollars per share) $ 20.47                                                            
Forfeited (in dollars per share) $ 31.98                                                            
Expired (in dollars per share) $ 0.00                                                            
Options outstanding at the end of the period (in dollars per share) $ 30.46 $ 30.57                                                          
Exercisable at the end of the period (in dollars per share) $ 30.99                                                            
Options exercisable and expected to vest at the end of the period (in dollars per share) $ 30.52                                                            
Weighted Average Remaining Contractual Term (Years)                                                              
Options outstanding at the end of the period 6 years 8 months 15 days                                                            
Exercisable at the end of the period 5 years 6 months 25 days                                                            
Options exercisable and expected to vest at the end of the period 6 years 7 months 15 days                                                            
Aggregate Intrinsic Value                                                              
Options outstanding at the end of the period (in dollars) 4,675,000                                                            
Exercisable at the end of the period (in dollars) 3,923,000                                                            
Options exercisable and expected to vest at the end of the period (in dollars) 4,597,000                                                            
Valuation Assumptions                                                              
Risk-free interest rate                         0.50% 0.40% 1.10%               0.10% 0.10% 0.10%            
Expected stock price volatility                         39.70% 46.80% 48.50%               29.70% 46.40% 49.00%            
Expected dividend yield                         3.00% 2.60% 2.20%               3.10% 2.80% 2.20%            
Expected life                         3 years 7 months 25 days 3 years 7 months 6 days 3 years 8 months 16 days               3 months 3 months 3 months            
Share-Based Compensation, Additional Disclosures                                                              
Weighted average fair values of stock options granted during the period (in dollars per share) $ 6.38 $ 8.92 $ 11.58                                       $ 5.46 $ 6.84 $ 9.35            
Total intrinsic value of options exercised (in dollars) 2,200,000 3,400,000 5,900,000                                                        
Cash received from option exercises 5,000,000 5,100,000 7,200,000                                                        
Excess tax benefits from share-based compensation 698,000 1,302,000 1,992,000                   300,000         400,000                          
Excess tax shortfall included in cash flows from operating activities                         800,000         300,000                          
Income tax benefit on recognized compensation cost                         900,000         3,800,000                          
Unrecognized compensation cost, net of estimated forfeitures, related to nonvested stock options/awards/units                         $ 3,900,000         $ 20,600,000                          
Weighted-average period for recognition of unrecognized compensation cost (in years/months)                         1 year 8 months 4 days         1 year 9 months 17 days                          
Initial vesting period during first fiscal year of grant                                                       7 months      
Vesting date                                                         Feb. 01, 2016    
Percentage of target performance shares expected to vest based on the satisfaction of certain performance-based conditions                                                           84.00%  
Fiscal year which award is subject to a performance condition                                                             2010
Period which award is subject to a performance condition                                                     5 years 9 months 9 months